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Abstract
Background: Smoking is one of the major modifiable risk factors contributing to early mortality for people with
serious mental illness. However, only a minority of service users access smoking cessation interventions and there
are concerns about the appropriateness of generic stop-smoking services for this group. The SCIMITAR (Smoking
Cessation Intervention for Severe Mental Ill-Health Trial) feasibility study explored the effectiveness of a bespoke
smoking cessation intervention delivered by mental health workers. This paper reports on the nested qualitative
study within the trial.
Methods: Qualitative semi-structured interviews were conducted with 13 service users receiving the intervention
and 3 of the MHSCPs (mental health smoking cessation practitioners) delivering the intervention. Topic guides
explored the perceived acceptability of the intervention particularly in contrast to generic stop-smoking services,
and perceptions of the implementation of the intervention in practice. Transcripts were analysed using the
Constant Comparative Method.
Results: Generic services were reported to be inappropriate for this group, due to concerns over stigma and a lack
of support from health professionals. The bespoke intervention was perceived positively, with both practitioners
and service users emphasising the benefits of flexibility and personalisation in delivery. The mental health
background of the practitioners was considered valuable not only due to their increased understanding of the
service users’ illness but also due to the more collaborative relationship style they employed. Challenges involved
delays in liaising with general practitioners and patient struggles with organisation and motivation, however the
MHSCP was considered to be well placed to address these problems.
Conclusion: The bespoke smoking cessation intervention was acceptable to service users and the both service
users and practitioners reported the value of a protected mental health worker role for delivering smoking
cessation to this group. The results have wider implications for understanding how to achieve integrated and
personalised care for this high-risk population and further underscore the need for sensitised smoking cessation
support for people with serious mental illness.
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Background
Service users with serious mental illness (SMI) have
higher rates of morbidity and premature mortality com-
pared to the general population, suffering the loss of an
estimated 13–20 years of life compared to those without
SMI [1]. These excess mortality rates are largely due to
modifiable risk factors such as smoking, but there are
recognised barriers at the individual, health care profes-
sional and systems level to addressing these problems in
this population [2–4]. The National Audit of Schizo-
phrenia in 2012 reported that the most serious deficits
in care for people with psychosis were in the monitoring
and management of their physical health problems [5].
There is, therefore, an urgent need to identify methods
for improving the assessment and management of phys-
ical health problems in service users with SMI and to
provide comprehensive preventative focussed services.
Smoking is recognised as one of the major modifiable
contributors to early mortality for this population [6].
Tobacco related conditions are estimated to comprise
approximately 53 % of all deaths of people with schizo-
phrenia and 48 % of people with bipolar disorder [7].
People with mental health problems consume 42 % of
the tobacco used in England and within this group
people with psychosis show one of the highest smoking
rates, with smoking suggested as a core factor respon-
sible for their health inequalities [8]. There is a higher
prevalence of smoking in people with psychosis (up to
80 % in people with schizophrenia [9]) compared to the
general population, and people with psychosis are more
likely to be classed as heavy smokers [10], therefore
representing an especially high risk group to be targeted
by smoking cessation programmes. Consequently, ad-
dressing smoking in this population is recognised as of
major clinical importance. In the UK, the Royal College
of Psychiatrist’s 2013 report “Whole Person Care:
Achieving parity between mental and physical health”
argued that parity could be achieved for people by
tackling the premature mortality rates of people with
mental illness, and specifically advised commissioners to
ensure that a major focus of their smoking cessation ser-
vices was on smokers with mental health problems [11].
However, despite being as motivated to stop smoking
as the general population, only a minority of those with
mental illness receive smoking cessation interventions
[12]. This may be due to commonly held misconceptions
that people with mental illness are unwilling or unable
to quit, with reports that services have ‘low aspirations’
in relation to their smoking status [11]. Opportunities to
engage service users with smoking cessation programmes
may therefore be missed, further exacerbating disparities
in care. Beyond the negative impact on health outcomes,
failure to address smoking behaviour is also discrimin-
atory and neglects the desire and the right of service users
with SMI to enter smoking cessation programmes [10]. As
well as barriers to accessing support, there are also con-
cerns about the suitability of traditional smoking cessation
programmes for this population [13, 14], with the frag-
mentation of mental and physical health services further
impeding attempts to provide holistic physical and mental
health care.
The SCIMITAR feasibility trial aimed to address these
barriers through the provision of a ‘bespoke smoking
cessation’ (BSC) service, where “bespoke” refers to the
specific tailoring of the intervention to people with se-
vere mental illness. The BSC was an individually tailored
service delivered by a skilled mental health practitioner
that aimed to work in conjunction with the participant
and the participant’s family doctor or mental health spe-
cialist. The intervention met NICE guidelines for smok-
ing cessation services at the time of the trial and was
delivered according to the Manual of Smoking Cessation
(guide for Counsellors and Practitioners [15]) which
forms the basis of client-centred smoking cessation
interventions in the NHS via the National Centre for Smok-
ing Cessation Training (NCSCT, http://www.ncsct.co.uk).
In the SCIMITAR trial the intervention was further adapted
to meet the particular needs of his population. Standard
NHS smoking cessation includes elements of personalisa-
tion, with tailoring of content to the individual recom-
mended in best practice guidelines [16], but the BSC aimed
to specifically tailor content and delivery for people with
serious mental illness. As well as delivery by a mental
health professional, this included, for example, providing
additional face-to-face support following relapse, recognis-
ing the motivations for smoking in the context of their
mental illness, a focus on home visits and collaboration
with other professionals involved in the service user’s care.)
Full details of the intervention are reported in both the
main trial paper and an accompanying paper with case
study examples of the MHSCPs work [17, 18]. The trial
found that smoking cessation was highest amongst individ-
uals receiving the BSC service and participants engaged
well with the service, in contrast to those in the usual care
group, none of whom accessed NHS smoking cessa-
tion services during the trial. It should be noted
however that the trial did not demonstrate a signifi-
cant difference between the intervention and control
arms. However, the trial was a feasibility study,
intended to establish the feasibility of recruiting par-
ticipants and delivering the intervention, and was
not intended to demonstrate effectiveness. A fully
powered trial is underway which will establish this
(funded by NIHR Health Technology Assessment,
reference HTA 11/136/52.)
The aim of the present study was to qualitatively ex-
plore the experiences of service users who received the
BSC intervention, particularly in comparison to their
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experience of standard stop-smoking services and in
light of their mental health difficulties. We also inter-
viewed the Mental Health Smoking Cessation Practi-
tioners (MHSCPs) who delivered the intervention at
each site, to explore their attitudes toward implementing
their training in the delivery of the intervention and to
intervention content.
Methods
Sampling was purposive, with invitations sent to partici-
pants in the intervention arm of the trial in order to
explore experience of receiving the intervention. We fur-
thermore aimed to purposively sample both service users
who had completed treatment with their MHSCP and
those who had withdrawn from treatment, Service users
who had withdrawn were specifically invited in order to
ensure that factors impacting on disengagement with the
BSC were captured and because we anticipated that dis-
engagement would be an indicator of low acceptability,
and this would ensure we captured both positive and
negative views.. 15 participants responded to the initial
invitation and expressed an interest in participating and
13 were interviewed (the remaining 2 participants were
not interviewed due to difficulties arranging the in-
terviews within the time frame of the study.) Inter-
views took place between August 2012 and January
2013. Ethics approval was sought and granted on
Oct 29, 2010, by Leeds (East) Research Ethics Com-
mittee (10/H1306/72). Participants provided written
consent prior to interviews taking place. After com-
pletion of the interview, as a token of thanks for
their time, the participant was offered a £10 gift
voucher. Participants were not notified of this vou-
cher until after the interview had been conducted so
as not to be coercive or cause undue influence over
the participant’s responses. Interviews were digitally
recorded and transcribed verbatim with permission
of the participants.
The topic guides were developed by the first three au-
thors and explored:
 Prior experience of smoking cessation, including
support received from other primary care or mental
health professionals.
 Acceptability of the intervention and satisfaction
with the bespoke smoking cessation service
(particularly in comparison to previous smoking
cessation interventions received).
 Service users’ engagement with the intervention;
with specific reference to barriers and facilitators to
compliance with smoking cessation interventions.
 Implementation in routine care, including
perceptions of who is best to deliver the BSC,
any anticipated barriers to implementation.
Sample
13 service users were recruited from across the 3 re-
cruitment sites (5 from Manchester, 6 from York and 2
from Hull). 3 MHSCPs, one from each site, were inter-
viewed.1 All 3 MHSCPs were female, had experience
working in Community Mental Health settings and none
had previous experience or training of smoking cessa-
tion. Of the 13 service users, 2 were female and the aver-
age age was 50 (range 32–68). Only 2 participants were
formally considered to have disengaged from the inter-
vention (had deliberately expressed a wish to withdraw
or to discontinue with the service). However, the inter-
views with both service users and MHSCPs indicated
that sustaining engagement was problematic for all par-
ticipants and that withdrawal was not directly related to
acceptability in the way we had anticipated. All partici-
pants expressed struggles with engagement (The issue of
engagement is reported in Theme 3.) rather than a sub-
set of patients withdrawing deliberately due to negative
perceptions of the intervention. Consequently we fina-
lised data collection once we believed data saturation
had been reached rather than attempting to further sam-
ple according to the original framework.
Participants in the qualitative sample had a similar
profile of smoking history and quit attempts to the trial
population overall [17] – the sample participants had
smoked for an average of 32 years and had tried to quit
5 times, with full trial sample having an average age of
27.1 and also an average 5 quit attempts. All of the par-
ticipants in the study were White British. Regarding
diagnosis, 5 of the service users had Bipolar disorder, 6
had Schizophrenia (3 reported Paranoid Schizophrenia)
and 2 had Depression with Psychosis.
Analysis
Transcripts were read independently by two authors (SK
and CP) and analysed using the Constant Comparison
method [19]. Constant comparison aims to inductively
identify themes through categorising and coding data
and exploring connections between them, repeating the
cycle across the data set until theoretical saturation is
achieved. Emergent themes were discussed and verified
with a third author (TB). Analysis was finalised prior to
the completion of the quantitative analysis and was
therefore blind to study outcome.
The MHSCPs transcripts were initially analysed inde-
pendently from the patient transcripts, but the analysis
was combined when preliminary readings suggested con-
sensus in core themes across the two data sets. We also
observed that novel insights could be synthesised across
the two samples to provide a holistic picture of the inter-
vention, with complementary perspectives and insights
on acceptability of the interventions and challenges en-
countered. Similarly, the transcripts of participants that
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completed the intervention and those that disengaged
were analysed together and synthesised to represent
challenges to engagement with smoking cessation, rather
than exploring differences between subsamples. Al-
though only 2 of the participants were formally consid-
ered to have ‘disengaged’ (having been discharged due to
a lack of contact with the MH-SCP), both service users
reported positive experiences with the intervention itself,
suggesting other circumstances may have contributed to
their disengagement, and even service users considered
to have engaged with treatment reported difficulties
maintaining motivation and planning future sessions. It
was therefore felt that these data were best captured
through over-arching themes rather than treated as
independent.
Results
We identified three main themes, reflecting the prob-
lems that service users with SMI encountered in terms
of smoking cessation in routine care, the perceived bene-
fits of the bespoke intervention for this population, and
finally barriers to the intervention in practice.
Theme 1: generic stop smoking services experienced as
unsuitable, and a lack of support from health professionals
for smoking cessation for service users with SMI
Participants reported a lack of support for smoking
cessation in current primary care and mental health
services, both implicitly through a lack of support for
cessation or through services appearing not to prioritise
smoking cessation for this group, and explicitly in the
form of professionals advising against quit attempts.
“When I go for an appointment and if they’re
catching up on their records, and it comes to smoking
and they say how many are you smoking, do you still
smoke. I say yeah, and they say, you know you should
really start trying to give up now, don’t you? You
know, just things like that. There’s nothing based
upon a reason to encourage me not to”. M1024
“Doctors are always recommending me to give up
smoking. Yes. I can’t really remember what they said.
They just say, ‘Do you smoke?’And I say yeah, and
they said, ‘Give up’. And the nurses, they say we can
help you but that’s all they say. It’s sort of…they can
give out patches but the only really advice they give is,
one time they said, ‘Now really try this time, [patient
name]. Really try’. And I was like alright. They just
signed the prescription and I take it away and try, so
that was that”. M1037
In other cases, health professionals actively discour-
aged smoking cessation attempts, either due to concerns
about the impact on service users’ mental health or due
to a perception that prescription only stop-smoking
medications are unsuitable for people with SMI:
“I’ve actually had a doctor turn round and say, after
quite an episode which was quite a lengthy episode,
and I talked about giving up, he said, oh no, you don’t
want to be giving up at the moment. So it was kind of
like a medical permission to carry on smoking… The
doctor might say, as he said, terrible thing smoking.
But never actually say, you should give up, and I’ll
refer you. I’ve had to ask for that. The last thing you
want to think about is giving up, that sort of
comment comes across”. Y1085
“[The practice nurse] just simply said, “We’re not
putting you on the Champix”, and the other one as
well, “Not putting you on them”. And that was it. I
was out the door, gone”. M1100
The MH-SCPs themselves acknowledged a lack of sup-
port for smoking cessation in people with SMI delivered
through existing services:
“Even though I knew it was an issue, it’s not
something that had really been at the forefront of my
mind, and thought that we necessarily should be
really targeting and addressing. So that did make me
rethink about my own practice, and about how we do
approach that with people… when I did the training,
it did make me think more that actually we don’t do
enough, and there is ways in with people. And aware
that I’ve been guilty in the past, especially when
working in acute in-patient units, thinking that maybe
this isn’t the best time for people to give up smoking,
and giving those messages out”. MHSCP1
Theme 2: the benefits of the MH-SCP role and the bespoke
intervention for service users with SMI
The perceived benefits of the MH-SCP included both
the bespoke nature of the intervention, with the practi-
tioner able to personalise the treatment to the individual
and their circumstances, and the sensitisation of the
intervention to the particular mental health needs of the
individual.
Providing a bespoke smoking cessation intervention
The bespoke nature of the intervention enabled person-
alisation to service users, both in terms of their individ-
ual needs (such as whether they preferred to cut down
or quit, preferring visits at home or elsewhere), their
condition (their mental health diagnosis, symptoms and
medications) and their specific health care context (in
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terms of working with the existing network of care co-
ordinators, GPs and nurse prescribers and psychiatrists).
“You work flexibly, they get someone that’s got some
understanding of their mental health issues, someone
who can work with, you know, have the time to work
with the other network of people that are involved
with them as well”. MHSCP 3
“It was individual to the person really, flexible to their
needs, like seeing them when they wanted within
reason and then not putting too much pressure on
them…just tailored to the person see what works for
each person… It was interesting how each person was
completely different what they wanted to do and what
they wanted from me and how motivated they were
and everything…you can’t just say ‘I’ve got to read this
script’”. MHSCP2
“there’s a mental health history, sort of checking out
who their key workers are, where they feel they are
with their mental health at that time, and the
psychiatric medication that they’re taking…stopping
smoking can have an impact on certain medications
so it was needing to know that, checking out that they
were okay for me to liaise with any mental health
workers, GPs et cetera. And it was just really getting a
feel for where they were at”. MHSCP 1
Providing smoking cessation sensitive to the mental health
needs of people with SMI
In regard to sensitisation, service users appreciated the
greater mental health knowledge and awareness of the
MH-SCPs, particularly in contrast to routine services
where service users reported anxiety about stigma at-
tached to their condition:
“It wasn’t just a stop smoking clinic for Tom, Dick
and Harry, she understood the mental health side,
which is obviously a big concern… Because I wouldn’t
go to a normal - because I’m frightened…Well [the
MHSCP] knows what I’ve got. Whereas if you go to a
normal stop smoking thing and they know you’ve got
mental health problems then it’s stigma isn’t it?…
you’ve got to trust the person who you’re talking to
and be comfortable with them, especially on mental
health issues”. H1098
The MH-SCPs also reported that service users they
saw had struggled with generic services being inappro-
priate and with concerns about stigma:
“I did have one chap that came…and he’d been to
normal standard NHS services, to a group, and he had
a diagnosis of bipolar, and … she’d given them all a
prescription request sheet for Champix. He went to
see his GP and his GP said, ‘I’m not giving you
Champix, you’ve got bipolar’. So he came back next
week, and he was the only one in the room that
hadn’t been given the Champix. And he said he felt
really awkward. ‘How do I explain why I couldn’t have
the Champix?’ He said, ‘I didn’t want to tell them it’s
because I had a mental health problem’”. MHSCP 1
The appreciation of the mental health background of
the MH-SCPs was not purely knowledge based however –
service users also emphasised the benefits of the more
collaborative or compassionate style of working that they
attributed to the mental health background of the practi-
tioners, again in contrast to their experiences with generic
stop-smoking services in Primary Care:
“The nurses, they don’t give you much time to talk
about it really. They just sort of pack you off with
some boxes of patches. [The MHSCP] listens to your
mental health problems as well, what you’re
thinking…she helped me to… feel at ease about not
being so hard on myself again if I’m suffering from
illness…she gave me a lot of peace of mind”. M1037
“I found that the relationship I had with [the
MHSCP], was such that she was supportive without
pushing. And it’s very much the case that she was
there to help, for advice, rather than to ram anything
down my throat…It becomes more of a therapeutic
relationship, rather than the nurses making me, or the
nurses leading me, whereas in a therapeutic relationship,
it’s the nurses walking along beside me, making the
journey with me rather than pushing me”. Y1053
The MHSCPs themselves also reported that their men-
tal health background enabled a more holistic approach
to smoking cessation:
“I think you can train anybody to deliver smoking
cessation, but it doesn’t work if you don’t understand
the issues of people with serious mental illness…you
can’t deliver it cold, you can’t just work on smoking
with somebody with a serious mental illness, if
they’re complex, they’ve got lots of other things going
on, you have to take them as a whole”. MHSCP 3
“It’s about engagement as well, that therapeutic
alliance, it’s all that sort of stuff. If somebody’s got
that with somebody and they have the smoking
cessation skills as well, then I think they’re best placed
to support that person”. MHSCP 1
Theme 3: reported challenges and barriers
The main reported challenges were at the service
level (concerning interactions with Primary Care) and
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at the patient level (concerning difficulties sustaining
engagement).
Service level barriers – integration with primary care
MH-SCPs reported that smoking cessation work was
best delivered by someone with protected time and
space for the role, which would be difficult to achieve in
current routine care:
“You could put this work into the mainstream, you
know, into CPNs [Community Psychiatric Nurses]
work, but I don’t know that everybody would do it,
that’s the thing, and how much time and attention
they would give, because you need to be quite
focused”. MHSCP 3
“Whether if they said to people in CMHTs just get
somebody who does a specific smoking cessation
speciality I don’t know if it would work because say at
[Community Residential Unit] they had a smoking
cessation worker there who I met and I’m like ‘Well
why am I here like?’And it’s because her role just was
eclipsed and she was just doing the general support
work. So you’d have to have a specific… you’d have to
be quite regimented in doing your work”. MHSCP 2
The practitioners also reported some barriers to work-
ing in Primary Care, specifically around effectively liais-
ing with GPs, which was also reported by service users
and which could cause delays to treatment:
“If the GP wouldn’t prescribe… then you’re chasing it
up and then when the client goes it’s not there and
they get annoyed that they’ve wasted a visit to the
doctors. Some GP surgeries refused to do it on my
recommendation and had to see the client. So then
the client had to make an appointment with the GP
which just didn’t happen. So then I’d say well I’ll give
you a letter to take with the doc… and then they lose
the letter”. MHSCP2
“I would have said, if anything, my own doctors let
[the MHSCP] down because she would put things in
to request for things that I needed, but they weren’t
coming through quick enough… I think we used to
sometimes do texts, can I just check, have you spoken
to my doctor? And she’d say, I’ve written the letter.
And I’d go across and try and pick up my
prescription, and it just wouldn’t be ready”. H1066
It was nevertheless emphasised that the MH-SCP role
was best placed within primary care, and that mental
health workers were uniquely placed to bring together
primary and secondary services for this group:
“A lot of the people with serious mental illness are
now seen in general practice and nowhere else…so
people are handed back to general practice, to benefit
the most people, there’d have to be something done in
primary care”. MHSCP3
“Well they’ve [mental health workers] got the skills,
they’ll already be working with the client group,
they’ll have the contacts, they’ll have the links…I think
it will fit together better. Because I think this should
be integral rather than seen as a separate service”.
MHSCP 1
Service-user level barriers – motivation and disorganisation
Both service users and practitioners acknowledged a
core problem around maintaining engagement and
motivation. Although all the service users who
joined the trial had expressed a desire to cut down
or quit smoking, sustaining their engagement, par-
ticularly during or after condition relapses could be
problematic and service users themselves reported
the need for support to be accessible when the ‘win-
dow of opportunity’ was open:
“It [starting the intervention] was over Christmas, and
before Christmas I really, really wanted to quit, and I
was ready to quit. But when I saw [the MHSCP], I
don’t think I was ready to quit… When things get a
bit rough, I start smoking. And that really [happened]
actually about a couple of month before I started
seeing [the MHSCP]. If I’d have started seeing her in
the first place, it would have been a different tale. I
would have quit, and I know I would. Timing, timing.
Getting the timing right”. Y1084
“I’d started to go through a little bit of an up and
downer, I felt as though I took it serious and I wanted
to do it, and then something would come along and
sort of like take my mind off everything… I just lost
all, you know, so it weren’t the fault of anybody, other
than the mind of me”. H1066
Other service users who struggled with cognitive or
memory problems also had difficulties sustaining their
smoking cessation:
“It was working and then all of a sudden I’m smoking
20 cigarettes a day, and it's like, to be honest, I can't
remember it … a lot of my memories from then are
very cloudy. I can't remember in detail things like, you
know, like you're asking, why did I start smoking
again”. M1024
The MH-SCPs reported that this problem was compli-
cated by the often chaotic lifestyles of people with SMI
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and their difficulties in organising and adhering to a
smoking cessation plan:
“She disengaged and was texting me saying, ‘Oh I’ve
not done too well this week so can you come next
week?’And I’d go and she wouldn’t be there… even if
I could say only one of my clients attended every
appointment [but] none of them did…I think it’s
reflective of the patient group really…. they’re just so
chaotic, very few of them had diaries and if they did it
wasn’t really like a diary it was a notebook that was all
upside down… they’d just write on one page that you
were coming and then they just put it in a drawer”.
MHSCP 2
However this problem was seen as reaffirming the
need for the personalised and proactive care that the
MHSCP could provide:
“She would lose the prescription, the house was, you
know, quite chaotic, she’d lose them, then she’d think
she’d run out of them and she’d get muddled with
them, so I had to do quite a bit of work around that
really, I mean, if I went in her house now, I know
exactly where she keeps everything and where she
loses everything! I don’t know if that was my role, but
it helps!”. MHSCP 3
“Mentally ill people probably do benefit from this
service because it's not that they can't think for
themselves in the same way as other people, but it's
more a case of they can't organise themselves or their
thoughts in the same way as other people. So they
probably just need that little bit of extra help”. M1024
Participants emphasised that problems with motiv-
ation should not be equated with not wanting to give up,
and that flexibility allowing them to re-engage would be
important:
“Probably [it’s] because at that time, it's too much for
them to add to what's going on in their lives … you
don't completely abandon them … So maybe if you
just keep… keep going back to them. You're saying
look, we're here and we'll keep letting you know we're
here”. M1024
Discussion
The study explored the acceptability of a bespoke smok-
ing intervention for people with SMI though interviews
with participants receiving the intervention and practi-
tioners trained to deliver it. The data suggest that the
intervention has the potential to increase both access to
and acceptability of smoking cessation for this high risk
group. The findings offer confirmation that generic
smoking cessation services are likely to be unsuitable for
this group, and that currently there is a lack of support
for smoking cessation offered in Primary Care. Partici-
pants reported that health professionals could explicitly
discourage quit attempts, consistent with concerns
about diagnostic and treatment overshadowing for
this group [20], which refers to the tendency for ser-
vices and health professionals to prioritise manage-
ment of one conditions (in this case SMI) at the
expense of others (physical health).
The mental health sensitised intervention offered here
was perceived as more appropriate and acceptable for
service users. The bespoke nature of the intervention en-
abled practitioners to tailor the intervention to individ-
uals in terms of both their mental health and medication
status and their individual preferences and levels of mo-
tivation. It was notable that both participants and practi-
tioners considered the mental health background of the
MH-SCPs to be important not only in terms of under-
standing medication needs or avoiding the anxiety
around stigma (both of which reduced the acceptability
of generic services), but also for the more collaborative
and supportive relationship style that the MHSCPs
employed and which was considered essential for work-
ing effectively with this patient group. It is well estab-
lished in the literature on dual diagnosis that additional
support and assertive outreach are crucial components
of tailoring interventions to this particular population
[21]. The study reported here demonstrates that service
users perceived the MH-SCPs as particularly suited to
building these more supportive relationships with them
and that they are equally valued in the context of smok-
ing cessation.
The MHSCPs also emphasised however the import-
ance of a protected space with protected time to focus
on smoking cessation outside of routine support work
typically provided by mental health workers and felt that
the role was best placed within primary care. It is recog-
nised that people with SMI can be disadvantaged by
fragmented care and risk ‘falling through the gaps’ [22]
and the data demonstrate how MHSCPs, if given a pro-
tected space to focus on smoking cessation, were able to
liaise between primary and secondary services. Given
that one-third of people with SMI are only seen in
primary care [23], this finding supports the need for
physical health initiatives for people with SMI to be inte-
grated within primary care.
Both service users and practitioners acknowledged that
wavering motivation levels and difficulties in organisa-
tion were a particular problem for this group. The need
to provide the intervention at ‘the right time’ suggests
that maintaining open access to the intervention is ne-
cessary so that service users can re-engage with
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treatment when they are ready, but there are clearly
questions around whether such a model is sustainable in
routine care. It may be more pragmatic for future re-
search to explore whether explicit motivational or or-
ganisational support, for example through provision of
text based reminders (which has been demonstrated to
improve anti-psychotic medication adherence [24])
could be built into the interventions to maintain engage-
ment. Another implication of this finding however, is
that problems with motivation and engagement should
not be construed as reflecting unwillingness to reduce or
quit smoking, but rather reflect the difficulties faced by
this group in maintaining abstinence or a reduced rate
of smoking over time.
Limitations
Firstly, the included sample size is small. However, the
emergent themes were highly consistent across partici-
pant and professional reports which support the robust-
ness of the findings. Secondly, inevitably participants in
the study reflect those who wished to engage with smok-
ing cessation services and findings may not generalise to
other service users with more complex needs and/or
lower levels of motivation. However, the aim of the trial
was to provide bespoke smoking cessation to service
users who requested treatment, not address motivation
to quit for those who may be unwilling, and motivation
was revealed to be complex and fluctuating even
amongst this group.
Thirdly, while service users in the study were positive
about their experiences with the MHSCPs, this may re-
flect that the practitioners who volunteered for the train-
ing were especially motivated or reflect the relatively
small number of cases each MHSCP had to manage.
The MHSCPs themselves also questioned whether their
role was feasible within routine care if protected space
could not be maintained. It will be important in larger
trials of such interventions to determine if the experi-
ences of the practitioners in the pilot study generalise to
larger cohorts of MHSCPs and also to address imple-
mentation within everyday workloads within existing
care services.
Finally, in terms of generalisability, only 2 of the inter-
viewed participants were female compared to 40 % in
the overall trial population, suggesting women were un-
derrepresented in the study. The sample was also exclu-
sively White British, indicating that further work is
necessary to explore the acceptability of a bespoke inter-
vention to other ethnic groups.
Implications
Better implementation of physical health care for people
with serious mental illness is a recognised priority inter-
nationally, with a need for greater understanding of how
to deliver integrated physical health programmes effect-
ively for this population [25]. In the UK, the Mental
Health Foundation report “Crossing Boundaries” identi-
fied nine areas of good practice which could be targeted
to achieve more integrated care, but highlighted that
having “staff who understand the holistic nature of
health care and have no professional defensiveness about
working closely with colleagues in other disciplines, and
with patients and families” (p7) were key to quality inte-
grated care [26]. The data collected here demonstrates
what this may look like in practice for physical health
initiatives for service users with psychosis. This would
involve staff, trained in delivery of both physical and
mental health interventions, who are able to effectively
liaise between primary and secondary care services, and
who also commit to working flexibly and sensitively with
service users with complex needs. The evidence reported
here can complement initiatives such as ReThink’s phys-
ical health pathway [27] through the identification of
professional and service level issues that could poten-
tially hinder the implementation of such initiatives in
practice.
Conclusions
Service users with SMI are often excluded from typical
stop-smoking services, either due to such services being
inappropriate for them or due to a lack of support to en-
gage with smoking cessation from health professionals.
The findings reported here demonstrate that, although
service users with SMI can struggle to sustain motiv-
ation and engage with treatments, they are willing to
engage with smoking cessation practitioners who can
understand their mental health problems and who are
able to work flexibly and collaboratively with both the
patient and with others involved in their care.
Endnotes
1Manchester and York each had one MH-SCP for the
duration of the study. Hull had two MH-SCPs. The sec-
ond Hull practitioner was unavailable for interview due
to emigration.
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